Correlation Between Eterna Therapeutics and Lexaria Bioscience

Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Lexaria Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Lexaria Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eterna Therapeutics and Lexaria Bioscience Corp, you can compare the effects of market volatilities on Eterna Therapeutics and Lexaria Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Lexaria Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Lexaria Bioscience.

Diversification Opportunities for Eterna Therapeutics and Lexaria Bioscience

0.1

Correlation Coefficient

Eterna Therapeutics  Lexaria Bioscience

Average diversification

The 3 months correlation between Eterna and Lexaria is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Lexaria Bioscience Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexaria Bioscience Corp and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Lexaria Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexaria Bioscience Corp has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Lexaria Bioscience go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and Lexaria Bioscience

Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the Lexaria Bioscience. But the stock apears to be less risky and, when comparing its historical volatility, Eterna Therapeutics is 10.48 times less risky than Lexaria Bioscience. The stock trades about -0.04 of its potential returns per unit of risk. The Lexaria Bioscience Corp is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  65.00  in Lexaria Bioscience Corp on December 4, 2024 and sell it today you would lose (40.00) from holding Lexaria Bioscience Corp or give up 61.54% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	82.45%
Values	Daily Returns

Eterna Therapeutics  vs.  Lexaria Bioscience Corp

Eterna Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Eterna Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Eterna Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Lexaria Bioscience Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lexaria Bioscience Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Eterna Therapeutics and Lexaria Bioscience

The main advantage of trading using opposite Eterna Therapeutics and Lexaria Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Lexaria Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexaria Bioscience will offset losses from the drop in Lexaria Bioscience's long position.

The idea behind Eterna Therapeutics and Lexaria Bioscience Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .